Phase II Study of Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Locally Advanced Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 31 Dec 2014
At a glance
- Drugs Ixabepilone (Primary) ; Carboplatin; Trastuzumab
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 05 Nov 2014 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov record.
- 15 Nov 2013 Planned end date changed from 1 Sep 2013 to 1 Nov 2014 as reported by ClinicalTrials.gov.